BiotechTubeBiotechTube
Home/Mayne Pharma Group/Scott Richards
SR

Scott Richards

Non-Executive Chairman

Mayne Pharma Group

Therapeutic Areas

Women's HealthDermatologyCNSAnti-infectivesCardiovascular

Mayne Pharma Group Pipeline

DrugIndicationPhase
Nextstellis (drospirenone/estetrol)Oral Contraception / Hormone TherapyApproved
Lidocaine Topical System 1.8%Postherpetic Neuralgia (PHN)Approved
Fabior (tazarotene) FoamAcne VulgarisApproved
Sorilux (calcipotriene) FoamPlaque PsoriasisApproved
Doryx (doxycycline hyclate) MPCSevere AcneApproved
Pipeline of Complex GenericsVariousDevelopment
Pipeline of 505(b)(2) ProductsVarious (Women's Health, Dermatology)Pre-clinical to Phase 3

Leadership Team at Mayne Pharma Group

SL
Shaun Larkin
Managing Director & Chief Executive Officer
DC
David Cowley
Chief Financial Officer
DM
Dr. Michael Thick
Chief Medical Officer
M(
Michael (Mick) O'Brien
Chief Commercial Officer, US Generics
DJ
Dr. James (Jim) Hall
President, Mayne Pharma International & President, Mayne Pharma USA (Branded)
BM
Brent Matthews
Chief Operating Officer
DM
Dr. Michelle Miller
Chief Scientific Officer (Development)
KC
Karen Cohen
Company Secretary & General Counsel
P(
Phillipa (Pippa) Leary
Non-Executive Director
J(
John (Rob) Kelly
Non-Executive Director
View full Mayne Pharma Group profile